Volume 25, Issue 1 pp. 116-124
ORIGINAL ARTICLE

The perspectives of survivors of Hodgkin lymphoma on lung cancer screening: A qualitative study

Dr Rachel Broadbent MBBCh

Corresponding Author

Dr Rachel Broadbent MBBCh

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK

NIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, UK

The Christie NHS Foundation Trust, Manchester, UK

Correspondence Rachel Broadbent, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Email: [email protected]

Search for more papers by this author
Dr Louise Gorman PhD

Dr Louise Gorman PhD

NIHR Greater Manchester Patient Safety Translational Research Centre, Centre for Mental Health and Safety, Division of Population Health, Health Services Research & Primary Care, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK

Search for more papers by this author
Professor Christopher J. Armitage PhD

Professor Christopher J. Armitage PhD

NIHR Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, UK

Manchester Centre for Health Psychology, Division of Psychology and Mental Health, University of Manchester, Manchester, UK

Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK

Search for more papers by this author
Professor John Radford MD

Professor John Radford MD

Manchester Cancer Research Centre, Manchester, UK

Search for more papers by this author
Dr Kim Linton PhD

Dr Kim Linton PhD

Manchester Cancer Research Centre, Manchester, UK

Search for more papers by this author
First published: 09 November 2021
Citations: 2

Abstract

Background

Hodgkin lymphoma survivors (HLS) are at excess risk of lung cancer as a consequence of HL treatment. HLS without a heavy smoking history are currently unable to access lung cancer screening (LCS) programmes aimed at ever smokers, and there is an unmet need to develop a targeted LCS programme. In this study we prospectively explored HLS perspectives on a future LCS programme, including motivating factors and potential barriers to participation, with the aim of identifying ways to optimise uptake in a future programme.

Methods

Semistructured telephone interviews were conducted with HLS, aged 18–80 and lymphoma-free for ≥5 years, selected from a clinical database (ADAPT). Participants provided informed consent. Data were analysed using inductive thematic analysis.

Results

Despite awareness of other late effects, most participants were unaware of their excess risk of lung cancer. Most were willing to participate in a future LCS programme, citing the potential curability of early-stage lung cancer and reassurance as motivating factors, whilst prior experience of healthcare was a facilitator. Whilst the screening test (a low dose CT scan) was considered acceptable, radiation risk was a concern for some and travel and time off work were potential barriers to participation.

Conclusions

Our results suggest that most HLS would participate in a future LCS programme, motivated by perceived benefits. Their feedback identified a need to develop educational materials addressing lung cancer risk and concerns about screening, including radiation risk. Such materials could be provided upon an invitation to LCS. Uptake in a future programme may be further optimized by offering flexible screening appointments close to home.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.

DATA AVAILABILITY STATEMENT

The data that supports the findings of this study are available in the supplementary material of this article

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.